InvestorsObserver
×
News Home

Sierra Oncology Inc (SRRA) Stock Adds 45.52% This Week; Should You Buy?

Thursday, April 14, 2022 01:15 PM | InvestorsObserver Analysts

Mentioned in this article

Sierra Oncology Inc (SRRA) Stock Adds 45.52% This Week; Should You Buy?

Sierra Oncology Inc (SRRA) stock is up 196.64% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives SRRA stock a score of 67 out of a possible 100.

That rank is primarily influenced by a short-term technical score of 100. SRRA's rank also includes a long-term technical score of 100. The fundamental score for SRRA is 0. In addition to the average rating from Wall Street analysts, SRRA stock has a mean target price of $45.20. This means analysts expect the stock to fall 17.46% over the next 12 months.
Overall Score - 67
SRRA has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on SRRA!

What's Happening with SRRA Stock Today

Sierra Oncology Inc (SRRA) stock has risen 0.02% while the S&P 500 is lower by -0.73% as of 1:14 PM on Thursday, Apr 14. SRRA is up $0.01 from the previous closing price of $54.75 on volume of 1,450,836 shares. Over the past year the S&P 500 has risen 7.02% while SRRA is up 196.64%. SRRA lost -$7.14 per share in the over the last 12 months. Click Here to get the full Stock Report for Sierra Oncology Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App